参考文献/References:
[1] Geijer H,Breimer LH.somatostatin receptor PET/CT in neuroen-docrine tumours:update on systematic review and meta-analysis[J].Eur J Nucl Med Mol Imaging,2013,40(11):1770-1780.
[2] Rufini V,Calcagni ML,Baum RP.Imaging of neuroendocrine tu-mors[J].Semin Nucl Med,2006,36(3):228-247.
[3] 王丽华,汪勇先,尹端祉.生长抑素及其类似物的标记技术的发展[J].核技术,2003,26(7):537-544.
[4] Roosenburg S,Laverman P,Joosten L,et al.PET and SPEC Tima-ging of a radiolabeled minigastrin analogue conjugated with DOTA.NOTA and NODAGA and labeled with 64Cu,68Ga and 111In[J].MolPharm,2014,11(11):3930-3937.
[5] Decristoforo C,Pickett RD,Verbruggen A.Feasibility and avai-lability of 68Ga-labelled peptides[J].Eur J Nucl Med Mol Imag-ing,2012,39 Suppl 1:S31-40.
[6] Zhernosekov KP,Filosofov DV,Baum RP,et al.Processing of gen-erator-produced 68Ga for medical application[J].J Nucl Med,2007,48(10):1741-1748.
[7] Hofmann M,Maecke H,Borner R,et al.Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC:preliminary data[J].Eur J Nucl Med,2001,28(12):1751-1757.
[8] Giesel FL,Stefanova M,Schwartz LH,et al.Impact of peptide re-ceptor radionuclide therapy on the 68Ga-DOTATOC-PET/CT uptake in normal tissue[J].Q J Nucl Med Mol Imaging,2013,57(2):171-176.
[9] Boy C,Heusner TA,Poeppel TD,et al.68Ga-DOTATOC PET/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue:correlation of sst2 mRNA and SUVmax[J].Eur J Nucl Med Mol Imaging,2011,38(7):1224-1236.
[10] Gabriel M,Decristoforo C,Kendler D,et al.68Ga-DOTA-Tyr3-oc-treotide PET in neuroendocrine tumors:comparison with somato-statin receptor scintigraphy and CT[J].J Nucl Med,2007,48(4):508-518.
[11] Mayerhoefer ME,Schuetz M,Magnaldi S,et al.Are contrast media required for 68Ga-DOTATOC PET/CT in patients with neuroen-docrine tumours of the abdomen?[J].Eur Radiol,2012,22(4):938-946.
[12] Ezziddin S,Lohmar J,Yong-Hing CJ,et al.Does the pretherapeutic tumor SUV in 68Ga DO TATOC PET predict the absorbed dose of 177Lu octreotate?[J].Clin Nucl Med,2012,37(6):e141-e147.
[13] Kroiss A,Putzer D,Decristoforo C,et al.68Ga-DOTA-TOC uptake in neuroendocrine tumour and healthy tissue:differentiation of physio-logical uptake and pathological processes in PET/CT[J].Eur J Nucl Med Mol Imaging,2013,40(4):514-523.
[14] Naswa N,Sharma P,Kumar R,et al.Usual and unusual neuroen-docrine tumor metastases on 68Ga-DOTANOC PET/CT:a pictorial review[J].Clin Nucl Med,2013,38(6):e239-e245.
[15] Fanti S,Ambrosini V,Tomassetti P,et al.Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET[J].Biomed Pharmacother,2008,62(10):667-671.
[16] Ambrosini V,Campana D,Tomassetti P,et al.68Ga-labelled pep-tides for diagnosis of gastroenteropancreatic NET[J].Eur J Nucl Med Mol Imaging,2012,39 Suppl 1:S52-60.
[17] Haug AR,Cindea-Drimus R,Auernhammer CJ,et al.The role of 68Ga-DOTATATE PET/CT in suspected neuroendocrine tumors[J].J Nucl Med,2012,53(11):1686-1692.
[18] Hofman MS,Kong G,Neels OC,et al.High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours[J].J Med Imaging Radiat Oncol,2012,56(1):40-47.
[19] Demirci E,Ocak M,Kanasakal L,et al.Comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-LAN PET/CT imaging in the same patient group with neuroendocrine tumours:preliminary results[J].Nucl Med Commun,2013,34(8):727-732.
[20] Kabasakal L,Demirci E,Ocak M,et al.Comparison of 68Ga-DOTATATE and 68Ga-DOTANOC PET/CT imaging in the same pa-tient group with neuroendocrine tumours[J].Eur J Nucl Med Mol Imaging,2012,39(8):1271-1277.
[21] Velikyan I,Sundin A,S?rensen J,et al.Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE:net uptake rate for accurate quantification[J].J Nucl Med,2014,55(2):204-210.
[22] Poeppel TD,Binse I,Petersenn S,et al.68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in functional imaging of neuroendocrine tumors[J].J Nucl Med,2011,52(12):1864-1870.
[23] Sandstr MM,Velikyan I,Garske-romn U,et al.Comparative biodis-tribution and radiation dosimetry of 68Ga-DOTATOC and 68Ga-DOTATATE in patients with neuroendocrine tumors[J].J Nucl Med,2013,54(10):1755-1759.
[24] Ruf J.Cost comparison of In-111-DTPA-octreotide scintigraphy and Ga-68-DOTATOC PET/CT in Germany:two sides of two different coins[J].Eur J Nucl Med Mol Imaging,2012,39(4):723-724.
相似文献/References:
[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[3]陈超坤,刘亮,傅飞先,等.囊性胸腺瘤和囊性畸胎瘤的影像学特征及鉴别诊断[J].国际放射医学核医学杂志,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
Chen Chaokun,Liu Liang,Fu Feixian,et al.Imaging features and differential diagnosis of cystic thymoma and cystic teratoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
[4]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[5]胡伟,赵军.小胶质细胞在AD炎性机制中的作用及其常见PET显像剂的应用进展[J].国际放射医学核医学杂志,2016,40(1):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
Hu Wei,Zhao Jun.Microglia’s Alzheimer disease inflammatory mechanisms and progress of its common application in PET imaging agents[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
[6]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[7]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[8]李海峰,张晓军,李云钢,等.国产模块LOOP环改良法合成11C-蛋氨酸[J].国际放射医学核医学杂志,2016,40(2):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
Li Haifeng,Zhang Xiaojun,Li Yungang,et al.Synthesis of 11C-methionine on home-made module by the improved LOOP method[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
[9]周翠屏,廖俊杰,何国华,等.原发性肠系膜巨大淋巴结增生症的MSCT表现与病理对照分析[J].国际放射医学核医学杂志,2016,40(3):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
Zhou Cuiping,Liao Junjie,He Guohua,et al.Primary mesenteric Castleman disease:MSCT findings with histopathologic correlation[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
[10]李海峰,张晓军,张锦明.多巴胺转运蛋白显像剂11C-β-CFT在帕金森病中的应用研究[J].国际放射医学核医学杂志,2016,40(3):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
Li Haifeng,Zhang Xiaojun,Zhang Jinming.Review of the use of dopamine transporter imaging agent 11C-β-CFT for diagnosing Parkinson disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
[11]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[12]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[13]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[14]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[15]李菲,黄俊星,张俊.18F-FDG PET/CT在食管癌中的临床应用[J].国际放射医学核医学杂志,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
Li Fei,Huang Junxing,Zhang Jun.The clinical application of 18F-FDG PET/CT in esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
[16]张巍,杨珂.18f正电子放射性药物生产及使用中医务人员的受照剂量研究[J].国际放射医学核医学杂志,2015,39(5):420.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 016]
zhang wei,yang ke..the research of radiation dose of 18f-fdg to pet/ct related personnel[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):420.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 016]
[17]曹登敏,林美福,陈文新,等.继发性骨淋巴瘤的18F-FDG PET/CT影像学表现[J].国际放射医学核医学杂志,2016,40(6):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
Cao Dengmin,Lin Meifu,Chen Wenxin,et al.Analysis on 18F-FDG PET/CT imaging characteristics in secondary bone lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
[18]李生栩,唐明灯,林端瑜,等.18F-FDG PET/CT在胸段食管鳞癌淋巴结转移中的诊断价值[J].国际放射医学核医学杂志,2016,40(6):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
Li Shengxu,Tang Mingdeng,Lin Duanyu,et al.Value of 18F-FDG PET/CT in detecting metastatic lymph nodes of thoracic esophageal squamous cell carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
[19]张莹莹,王振光,武凤玉,等.特发性肺间质纤维化HRCT病变区与非病变区18F-FDG PET/CT表现分析[J].国际放射医学核医学杂志,2016,40(6):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
Zhang Yingying,Wang Zhenguang,Wu Fengyu,et al.18F-FDG PET/CT imaging analysis of regions with abnormal and normal pulmonary parenchyma on high resolution CT in idiopathic pulmonary fibrosis patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
[20]张毓艺,姚稚明.18F-FDG PET/CT对非小细胞肺癌淋巴结分期诊断价值的研究进展[J].国际放射医学核医学杂志,2016,40(6):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
Zhang Yuyi,Yao Zhiming.The progress of 18F-FDG PET/CT in the diagnosis of N-staging of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]